Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ST2 levels and neurodegenerative diseases: is this a significant relation?
Arora H, Javed B, Kutikuppala LVS, Chaurasia M, Khullar K, Kannan S, Golla V. Arora H, et al. Among authors: kannan s. Ann Med Surg (Lond). 2024 Mar 12;86(5):2812-2817. doi: 10.1097/MS9.0000000000001939. eCollection 2024 May. Ann Med Surg (Lond). 2024. PMID: 38694387 Free PMC article. Review.
Correction: The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections.
Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, Aslan AT, Leone M, Bassetti M, Morris AC, Arvaniti K, Paiva JA, Ferrer R, Qiu H, Montrucchio G, Cortegiani A, Kayaaslan B, De Bus L, De Waele JJ, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP), and the OUTCOMEREA Network. Buetti N, et al. Intensive Care Med. 2024 Apr 8. doi: 10.1007/s00134-024-07415-6. Online ahead of print. Intensive Care Med. 2024. PMID: 38587556 No abstract available.
Late urinary toxicity and QOL with pelvic radiotherapy for high-risk prostate cancer: Dose-effect relations in the POP-RT randomized phase III trial.
Maitre P, Maheshwari G, Sarkar J, Singh P, Kannan S, Dutta S, Phurailatpam R, Raveendran V, Prakash G, Menon S, Joshi A, Pal M, Arora A, Murthy V. Maitre P, et al. Among authors: kannan s. Int J Radiat Oncol Biol Phys. 2024 Mar 27:S0360-3016(24)00439-5. doi: 10.1016/j.ijrobp.2024.03.023. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38552989
1,372 results